百花齐放，促进中国二尖瓣介入治疗事业蓬勃发展
朱齐丰,刘先宝,王建安
摘要(Abstract)：
<正>二尖瓣反流（mitral regurgitation, MR）是最常见的瓣膜疾病之一，其发病率随着年龄增长而增高，75岁以上人群发病率高达10%以上~([1-2])。高龄重症二尖瓣反流是临床治疗的难点，患者往往因心功能低下、合并症多、高龄等因素无法耐受外科手术，经导管二尖瓣介入治疗凭借其创伤小的优势为这些患者提供了新的治疗选择。二尖瓣介入器械主要分为经导管二尖瓣修复（transcatheter mitral valve repair,TMVr）和经导管二尖瓣置换（transcatheter mitral valve replacement,TMVR）两类，
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 朱齐丰,刘先宝,王建安
参考文献(References)：
- [1]Nkomo VT,Gardin JM,Skelton TN,et al.Burden of valvular heart diseases:a population-based study[J].Lancet,2006,368(9540):1005-1011.DOI:10.1016/S0140-6736(06)69208-8.
- [2]Xu H,Liu Q,Cao K,et al.Distribution,characteristics,and management of older patients with valvular heart disease in China:China-DVD study[J].JACC Asia,2022,2(3):354-365.DOI:10.1016/j.jacasi.2021.11.013.
- [3]马云龙,何明俊,郝翔,等.经导管二尖瓣缘对缘修复治疗二尖瓣脱垂伴裂隙1例[J].中国介入心脏病学杂志,2024,32(5):284-287.DOI:10.3969/j.issn.1004-8812.2024.05.009.
- [4]高政,刘伟丽,屈占军,等.经导管穿刺房间隔行二尖瓣瓣中瓣置换治疗二尖瓣生物瓣膜衰败1例[J].中国介入心脏病学杂志,2024,32(5):288-290.DOI:10.3969/j.issn.1004-8812.2024.05.010.
- [5]邹志瑶,朱达,陈一鸣,等.经导管二尖瓣缘对缘修复术的超快通道麻醉经验总结[J].中国介入心脏病学杂志,2024,32(5):250-256.DOI:10.3969/j.issn.1004-8812.2024.05.003.
- [6]张斌,裴志强,马登峰,等.脂蛋白(α)与二尖瓣环钙化关系的研究进展[J].中国介入心脏病学杂志,2024,32(5):261-265.DOI:10.3969/j.issn.1004-8812.2024.05.005.
- [7]何明俊,韩克.急性缺血性二尖瓣反流的缘对缘治疗[J].中国介入心脏病学杂志,2024,32(5):276-283.DOI:10.3969/j.issn.1004-8812.2024.05.008.
- [8]Szerlip M,Spargias K S,Makkar R,et al.2-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study[J].JACC Cardiovasc Interv,2021,14(14):1538-1548.DOI:10.1016/j.jcin.2021.04.001.
- [9]Feldman T,Kar S,Elmariah S,et al.Randomized comparison of percutaneous repair and surgery for mitral regurgitation:5-year results of EVERESTⅡ[J].J Am Coll Cardiol,2015,66(25):2844-2854.DOI:10.1016/j.jacc.2015.10.018.
- [10]Stone GW,Lindenfeld J,Abraham WT,et al.Transcatheter mitral-valve repair in patients with heart failure[J].N Engl J Med,2018,379(24):2307-2318.DOI:10.1056/NEJMoa1806640.
- [11]Liu X,Chen M,Han Y,et al.First-in-human study of the novel transcatheter mitral valve repair system for mitral regurgitation[J].JACC Asia,2022,2(3):390-394.DOI:10.1016/j.jacasi.2022.03.010.
- [12]Wang J,Liu X,Pu Z,et al.Safety and efficacy of the DragonFly system for transcatheter valve repair of degenerativemitral regurgitation:one-year results of the DRAGONFLY-DMR trial[J].Euro Intervention,2024,20(4):e239-e249.DOI:10.4244/EIJ-D-23-00361.
- [13]Pan W,Long Y,Guo Y,et al.Transapical edgeto-edge repair system in high-risk patients with degenerative mitral regurgitation:a multicenter trial(CLAMP-2)[J].JACC Cardiovasc Interv,2023,16(18):2340-2342.DOI:10.1016/j.jcin.2023.06.035.
- [14]Witte KK,Lipiecki J,Siminiak T,et al.The REDUCE FMR trial:a randomized sham-controlled study of percutaneous mitral annuloplasty in functional mitral regurgitation[J].JACC Heart Fail,2019,7(11):945-955.DOI:10.1016/j.jchf.2019.06.011.
- [15]Messika-Zeitoun D,Nickenig G,Latib A,et al.Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system:1 year outcomes[J].Eur Heart J,2019,40(5):466-472.DOI:10.1093/eurheartj/ehy424.
- [16]Rogers T,Greenbaum AB,Babaliaros VC,et al.Transcatheter mitral cerclage ventriculoplasty:from bench to bedside[J].JACC Cardiovasc Interv,2022,15(12):1249-1263.DOI:10.1016/j.jcin.2022.04.013.
- [17]Patterson T,Gregson J,Erglis A,et al.Two-year outcomes from the Mitral Valve Repair Clinical(MAVERIC)trial:a novel percutaneous treatment of functional mitral regurgitation[J].Eur J Heart Fail,2021,23(10):1775-1783.DOI:10.1002/ejhf.2321.
- [18]Wang LH,Pu ZX,Kong MJ,et al.The first four cases of successful NeoChord procedure in mainland China[J].World J Emerg Med,2019,10(3):133-137.DOI:10.5847/wjem.j.1920-8642.2019.03.001.
- [19]Hell MM,Wild MG,Baldus S,et al.Transapical mitral valve replacement:1-year results of the real-world Tendyne European experience registry[J].JACC Cardiovasc Interv,2024,17(5):648-661.DOI:10.1016/j.jcin.2023.12.027.
- [20]Bapat V,Weiss E,Bajwa T,et al.2-year clinical and echocardiography follow-up of transcatheter mitral valve replacement with the transapical Intrepid system[J].JACC Cardiovasc Interv,2024,S1936-8798(24)00527-2.DOI:10.1016/j.jcin.2024.02.033.Online ahead of print.